AMPH
Price
$29.43
Change
+$0.24 (+0.82%)
Updated
Sep 5, 04:59 PM (EDT)
Capitalization
1.37B
66 days until earnings call
HKMPF
Price
$24.50
Change
+$0.14 (+0.57%)
Updated
Aug 25 closing price
Capitalization
5.13B
Interact to see
Advertisement

AMPH vs HKMPF

Header iconAMPH vs HKMPF Comparison
Open Charts AMPH vs HKMPFBanner chart's image
Amphastar Pharmaceuticals
Price$29.43
Change+$0.24 (+0.82%)
Volume$5.49K
Capitalization1.37B
Hikma Pharmaceuticals
Price$24.50
Change+$0.14 (+0.57%)
Volume$2.22K
Capitalization5.13B
AMPH vs HKMPF Comparison Chart in %
Loading...
AMPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HKMPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMPH vs. HKMPF commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMPH is a Buy and HKMPF is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (AMPH: $29.19 vs. HKMPF: $24.50)
Brand notoriety: AMPH and HKMPF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: AMPH: 104% vs. HKMPF: 352%
Market capitalization -- AMPH: $1.37B vs. HKMPF: $5.13B
AMPH [@Pharmaceuticals: Generic] is valued at $1.37B. HKMPF’s [@Pharmaceuticals: Generic] market capitalization is $5.13B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMPH’s FA Score shows that 0 FA rating(s) are green whileHKMPF’s FA Score has 1 green FA rating(s).

  • AMPH’s FA Score: 0 green, 5 red.
  • HKMPF’s FA Score: 1 green, 4 red.
According to our system of comparison, AMPH is a better buy in the long-term than HKMPF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMPH’s TA Score shows that 4 TA indicator(s) are bullish while HKMPF’s TA Score has 4 bullish TA indicator(s).

  • AMPH’s TA Score: 4 bullish, 6 bearish.
  • HKMPF’s TA Score: 4 bullish, 2 bearish.
According to our system of comparison, HKMPF is a better buy in the short-term than AMPH.

Price Growth

AMPH (@Pharmaceuticals: Generic) experienced а -3.54% price change this week, while HKMPF (@Pharmaceuticals: Generic) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -0.80%. For the same industry, the average monthly price growth was +10.24%, and the average quarterly price growth was +86.08%.

Reported Earning Dates

AMPH is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (-0.80% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HKMPF($5.13B) has a higher market cap than AMPH($1.37B). HKMPF has higher P/E ratio than AMPH: HKMPF (14.67) vs AMPH (10.93). HKMPF YTD gains are higher at: 5.050 vs. AMPH (-21.384). HKMPF has higher annual earnings (EBITDA): 734M vs. AMPH (248M). HKMPF (236M) and AMPH (232M) have equal amount of cash in the bank . AMPH has less debt than HKMPF: AMPH (655M) vs HKMPF (1.56B). HKMPF has higher revenues than AMPH: HKMPF (3.22B) vs AMPH (723M).
AMPHHKMPFAMPH / HKMPF
Capitalization1.37B5.13B27%
EBITDA248M734M34%
Gain YTD-21.3845.050-423%
P/E Ratio10.9314.6775%
Revenue723M3.22B22%
Total Cash232M236M98%
Total Debt655M1.56B42%
FUNDAMENTALS RATINGS
AMPH vs HKMPF: Fundamental Ratings
AMPH
HKMPF
OUTLOOK RATING
1..100
2037
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
10
Undervalued
PROFIT vs RISK RATING
1..100
82100
SMR RATING
1..100
4879
PRICE GROWTH RATING
1..100
4477
P/E GROWTH RATING
1..100
8295
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HKMPF's Valuation (10) in the null industry is somewhat better than the same rating for AMPH (67) in the Pharmaceuticals Other industry. This means that HKMPF’s stock grew somewhat faster than AMPH’s over the last 12 months.

AMPH's Profit vs Risk Rating (82) in the Pharmaceuticals Other industry is in the same range as HKMPF (100) in the null industry. This means that AMPH’s stock grew similarly to HKMPF’s over the last 12 months.

AMPH's SMR Rating (48) in the Pharmaceuticals Other industry is in the same range as HKMPF (79) in the null industry. This means that AMPH’s stock grew similarly to HKMPF’s over the last 12 months.

AMPH's Price Growth Rating (44) in the Pharmaceuticals Other industry is somewhat better than the same rating for HKMPF (77) in the null industry. This means that AMPH’s stock grew somewhat faster than HKMPF’s over the last 12 months.

AMPH's P/E Growth Rating (82) in the Pharmaceuticals Other industry is in the same range as HKMPF (95) in the null industry. This means that AMPH’s stock grew similarly to HKMPF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMPHHKMPF
RSI
ODDS (%)
Bearish Trend 2 days ago
64%
Bullish Trend 2 days ago
26%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
62%
Bearish Trend 2 days ago
38%
Momentum
ODDS (%)
Bearish Trend 2 days ago
76%
Bullish Trend 2 days ago
31%
MACD
ODDS (%)
Bearish Trend 2 days ago
69%
Bullish Trend 2 days ago
24%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
70%
Bullish Trend 2 days ago
32%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
39%
Advances
ODDS (%)
Bullish Trend 4 days ago
73%
N/A
Declines
ODDS (%)
Bearish Trend 2 days ago
71%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
53%
Bullish Trend 2 days ago
22%
Aroon
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
49%
View a ticker or compare two or three
Interact to see
Advertisement
AMPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HKMPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BWLCX23.980.16
+0.67%
American Beacon Man Lg Cp Value C
FAFDX38.83N/A
N/A
Fidelity Advisor Financials A
WIMVX12.08N/A
N/A
Segall Bryant & Hamill Glb All Cp Inst
PQIAX42.49N/A
N/A
Principal Equity Income A
IYBFX25.16N/A
N/A
Macquarie Balanced Fund Class R

AMPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMPH has been loosely correlated with COLL. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if AMPH jumps, then COLL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMPH
1D Price
Change %
AMPH100%
-0.68%
COLL - AMPH
39%
Loosely correlated
-0.91%
AMRX - AMPH
36%
Loosely correlated
+0.10%
ZTS - AMPH
33%
Poorly correlated
+0.51%
HROW - AMPH
31%
Poorly correlated
-3.05%
BHC - AMPH
30%
Poorly correlated
-1.90%
More